Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.250
-0.150 (-4.41%)
At close: May 15, 2026, 4:00 PM EDT
3.270
+0.020 (0.62%)
After-hours: May 15, 2026, 7:34 PM EDT
Rocket Pharmaceuticals Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$29.54
Upside
+808.92%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +238.46% | May 11, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +176.92% | Mar 30, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +238.46% | Mar 27, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $2 → $3 | Strong Sell | Maintains | $2 → $3 | -7.69% | Mar 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +207.69% | Feb 27, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +146.15% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades $261 → $263 | Buy → Sell | Downgrades | $261 → $263 | +7,992.31% | Nov 18, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +238.46% | Oct 14, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +115.38% | Oct 3, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $4 → $10 | Hold → Strong Buy | Upgrades | $4 → $10 | +207.69% | Aug 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +238.46% | Aug 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +238.46% | Aug 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +146.15% | Aug 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $9 → $4 | Strong Buy → Hold | Downgrades | $9 → $4 | +23.08% | Jul 25, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +207.69% | Jul 25, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $12 | Strong Buy | Maintains | $17 → $12 | +269.23% | Jul 24, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.